MEDTEKPARTNER RESEARCH AS
Operating
Å tilby forsknings og kliniske tjenester til medisinsk-tekniske,
farmasøytiske, medisinske, bioteknologiske og helserelaterte
selskaper. Dette inkluderer planlegging, gjennomføring og styring av
kliniske studier, biostatistiske analyser, datamanagement,
regulatorisk rådgivning og alle relaterte tjenester. Selskapet kan
også engasjere seg i utvikling og kommersialisering av egne medisinske
produkter og teknologier.
Annen forskning og annet utviklingsarbeid innen naturvitenskap
og teknikk.
Organization
- CEO
- MR
- Chairman of the board
- MR
- Years since formation
- 2 years
- since Oct 3, 2023
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 1,000
- 1 share class
- Total number of shareholders
- 3
- 2 companies, 1 person
- Belongs to group of
Financials
- Total equity 2024
- 30,000
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares | 
|---|---|---|
| MR | Managing Director/CEO | - | 
Board
| Name | Role | Shares | 
|---|---|---|
| MR | Chairman | - | 
| AS | Board Member | 40.4 % indirectly | 
| FK | Board Member | - | 
| ET | Board Member | 10 % indirectly | 
| PB | Board Member | 10 % directly | 
Top 10 individual shareholders
| Name | Role | Shares | 
|---|---|---|
| AS | Board Member | 40.4 % indirectly | 
| FK | - | 39.6 % indirectly | 
| PB | Board Member | 10 % directly | 
| ET | Board Member | 10 % indirectly | 
Last update: Oct 31, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share | 
|---|---|---|---|
| Ordinary shares | 800 | 80 % | |
| Ordinary shares | 100 | 10 % | |
| PB | Ordinary shares | 100 | 10 % | 
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 7,640,054Operating profit 2024: NOK 80,994Employees: 7
Financials
in NOK
Summary
| Year | 2024 | 
|---|---|
| Total operating income | 0 | 
| Annual Total Result | 0 | 
| Total assets | 30,000 | 
| Total liabilities | 0 | 
| Total equity | 30,000 | 
P&L
| Year | 2024 | 
|---|---|
| Total operating income | 0 | 
| Total operating costs | 0 | 
| Operating result | 0 | 
| Financial income/costs | 0 | 
| Profit before tax | 0 | 
| Total tax & extraordinary income/cost | 0 | 
| Annual Total Result | 0 | 
Balance overview
| Year | 2024 | 
|---|---|
| Total fixed assets | 0 | 
| Total current assets | 30,000 | 
| Total assets | 30,000 | 
| Short term debt | 0 | 
| Long term debt | 0 | 
| Total liabilities | 0 | 
| Contributed capital | 30,000 | 
| Retained earnings | 0 | 
| Total equity | 30,000 | 
| Total equity and liabilities | 30,000 | 
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises